Novartis v. Breckenridge: Obviousness-Type Double Patenting Explained
Without trying to summarize this well-written opinion by Judge Chen, I simply recommend that you store it somewhere and pull it out when you have a tricky obviousness-type double-patenting situation and want a thorough review of the doctrine. The opinion reviews both the facts of the present dispute, which involved pre- and post-URAA filing dates, and of the precedent, a Gilead case and an AbbVie case – with clear charts as well.
Back to All Resources